Masashi Ohe

705 total citations
50 papers, 482 citations indexed

About

Masashi Ohe is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Surgery. According to data from OpenAlex, Masashi Ohe has authored 50 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Hematology and 9 papers in Surgery. Recurrent topics in Masashi Ohe's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Platelet Disorders and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Masashi Ohe is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Platelet Disorders and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Masashi Ohe collaborates with scholars based in Japan and Türkiye. Masashi Ohe's co-authors include Yoshikazu Kawakami, Etsuro Yamaguchi, Yukihiko Homma, N. Hizawa, Satoshi Hashino, Akichika Itoh, Ken Furuya, N. Ohnuma, Ken Furuya and Mitsuru Munakata and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Thorax.

In The Last Decade

Masashi Ohe

45 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Ohe Japan 12 151 148 88 78 62 50 482
Marcus Krüger Germany 14 67 0.4× 97 0.7× 115 1.3× 31 0.4× 42 0.7× 42 518
Jeffrey A. Yung United States 4 284 1.9× 85 0.6× 114 1.3× 23 0.3× 25 0.4× 6 489
Benoı̂t Vendrely France 13 119 0.8× 45 0.3× 64 0.7× 30 0.4× 32 0.5× 19 537
J.F. Gómez-Cerezo Spain 11 67 0.4× 74 0.5× 199 2.3× 26 0.3× 54 0.9× 43 471
Jonathan Wong United Kingdom 13 93 0.6× 63 0.4× 92 1.0× 27 0.3× 67 1.1× 22 415
Ramit Maoz‐Segal Israel 9 41 0.3× 25 0.2× 66 0.8× 43 0.6× 45 0.7× 22 489
D. Griffin Ireland 12 35 0.2× 85 0.6× 29 0.3× 58 0.7× 35 0.6× 31 436
Eduardo Hernández Spain 10 57 0.4× 150 1.0× 138 1.6× 52 0.7× 72 1.2× 27 542
Frank G. Boineau United States 13 47 0.3× 107 0.7× 70 0.8× 19 0.2× 80 1.3× 35 552
Özlem Keskin Türkiye 11 146 1.0× 121 0.8× 34 0.4× 15 0.2× 27 0.4× 34 325

Countries citing papers authored by Masashi Ohe

Since Specialization
Citations

This map shows the geographic impact of Masashi Ohe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Ohe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Ohe more than expected).

Fields of papers citing papers by Masashi Ohe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Ohe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Ohe. The network helps show where Masashi Ohe may publish in the future.

Co-authorship network of co-authors of Masashi Ohe

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Ohe. A scholar is included among the top collaborators of Masashi Ohe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Ohe. Masashi Ohe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohe, Masashi. (2021). Multi-drug Treatment for COVID-19-induced Acute Respiratory Distress Syndrome. Turkish Journal of Pharmaceutical Sciences. 19(1). 101–103. 3 indexed citations
2.
Ohe, Masashi, Ken Furuya, & Houman Goudarzi. (2021). Immune Thrombocytopenia Treated with Intravenous Erythromycin. Gazi Medical Journal. 32(4).
3.
Ohe, Masashi, Ken Furuya, & Houman Goudarzi. (2021). Multidrug treatment for COVID-19. Drug Discoveries & Therapeutics. 15(1). 39–41. 3 indexed citations
4.
Ohe, Masashi, Masaru Baba, Haruki Shida, Ken Furuya, & Katsuhisa Kogawa. (2019). A case of follicular lymphoma accompanied with chylous ascites. Blood Research. 54(3). 163–163. 1 indexed citations
5.
Ohe, Masashi. (2019). Azathioprine-induced Myelodysplasia Mimicking Myelodysplastic Syndrome. The Ewha Medical Journal. 42(3). 46–46.
6.
Ohe, Masashi, et al.. (2018). Methotrexate-induced myelodysplasia mimicking myelodysplastic syndrome. Blood Research. 53(4). 268–268. 3 indexed citations
7.
Ohe, Masashi, Haruki Shida, Tetsuya Horita, & Ken Furuya. (2018). Successful additional clarithromycin and tacrolimus treatment for hypereosinophilia associated with eosinophilic granulomatosis with polyangiitis. Translational and Clinical Pharmacology. 26(2). 60–60. 1 indexed citations
8.
Ikari, Tomoo, Katsura Nagai, Masashi Ohe, Toshiyuki Harada, & Yasushi Akiyama. (2017). Multiple cavities with halo sign in a case of invasive pulmonary aspergillosis during therapy for drug-induced hypersensitivity syndrome. Respiratory Medicine Case Reports. 21. 124–128. 5 indexed citations
9.
Ohe, Masashi, et al.. (2017). A case of adult-onset Still's disease accompanied by pseudo-gray platelet syndrome. Blood Research. 52(3). 231–231. 1 indexed citations
10.
Ohe, Masashi & Satoshi Hashino. (2016). Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin. Blood Research. 51(2). 139–139. 2 indexed citations
11.
Ohe, Masashi & Satoshi Hashino. (2016). A case of idiopathic pulmonary fibrosis treated with clarithromycin. Eastern Journal Of Medicine. 21(1). 39–41.
12.
Ohe, Masashi, et al.. (2015). Late-onset Systemic Lupus Erythematosus with Protein-losing Enteropathy, Vitiligo, and Diffuse Alveolar Hemorrhage. The Ewha Medical Journal. 38(3). 121–121. 1 indexed citations
13.
Ohe, Masashi, Satoshi Hashino, & Atsuo Hattori. (2012). Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. The Korean Journal of Hematology. 47(4). 293–293. 7 indexed citations
14.
Ohe, Masashi & Satoshi Hashino. (2011). A case of follicular B-cell lymphoma treated using clarithromycin. The Korean Journal of Hematology. 46(3). 203–203. 5 indexed citations
15.
Karashima, Shigehiro, Yoshiyu Takeda, Yuan Cheng, et al.. (2011). Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma. Steroids. 76(12). 1363–1366. 12 indexed citations
16.
Ohe, Masashi & Satoshi Hashino. (2011). Successful treatment with erythromycin for idiopathic thrombocytopenic purpura. The Korean Journal of Hematology. 46(2). 139–139. 11 indexed citations
17.
Hasegawa, Akiko, et al.. (2009). Intravascular large B-cell lymphoma associated with hypoalbuminemia and pleural effusion. 68(4). 358–365. 1 indexed citations
18.
Ishimaru, Ken, et al.. (2004). A CASE OF DELAYED HEMOLYTIC TRANSFUSION REACTION PROBABLY CAUSED BY A PRIMARY IMMUNE RESPONSE. Journal of the Japan Society of Blood Transfusion. 50(6). 768–773. 4 indexed citations
19.
Amishima, Masaru, M. Munakata, Yoshinori Ohtsuka, et al.. (1995). Dairy Farmers Have Increased Methacholine Bronchial Responsiveness Independent of Sensitization to Mold Antigens. American Journal of Respiratory and Critical Care Medicine. 151(6). 1794–1798. 15 indexed citations
20.
Ohtsuka, Yoshinori, Mitsuru Munakata, Yukihiko Homma, et al.. (1995). Three cases of idiopathic interstitial pneumonia with bullae seen in schoolteachers. American Journal of Industrial Medicine. 28(3). 425–435. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026